Blue Path Capital Management, LLC Johnson & Johnson Transaction History

Blue Path Capital Management, LLC

  • $143 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024
SELL
$155.22 - $162.74 $824,839 - $864,800
-5,314 Reduced 79.12%
1,402 $222 Million
Q4 2023

Jan 11, 2024
BUY
$145.6 - $158.88 $160,742 - $175,403
1,104 Added 19.67%
6,716 $1.09 Billion
Q3 2023

Oct 25, 2023
BUY
$155.75 - $174.48 $874,069 - $979,181
5,612 New
5,612 $874 Million

Others Institutions Holding JNJ

# of Institutions
4,161
Shares Held
1.69B
Call Options Held
12.5M
Put Options Held
10.3M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Blue Path Capital Management, LLC Portfolio

Follow Blue Path Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Path Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Path Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email